Dr. Alex Morgan brings a broad analytical perspective to biotechnology, healthcare innovation, and life sciences strategy. With experience spanning research, industry analysis, and market intelligence, Alex examines how scientific progress, capital flows, and policy decisions intersect. At The Catalyst Brief, Alex focuses on connecting developments across domains to surface the strategic implications that matter most to industry leaders.
134 articlesMostly Regulatory & Policy and Biopharmaceutical Industry
Biopharmaceutical IndustryThe healthcare sector in January experienced significant personnel changes with companies such as Aidoc, Suki, and Particle Health introducing new executives while firms including Takeda, Trinity Health, and Horizon BCBS New Jersey underwent layoffs. This overview delves into the dynamics behind these moves and their implications.
Dr. Alex MorganJan 31, 2026
Biopharmaceutical IndustryData from BioSpace underscores the rising competitiveness in biopharma employment, with a majority of both employed and unemployed professionals planning to seek new opportunities in 2026.
Dr. Alex MorganJan 22, 2026